Stay in Touch
While I rely heavily on my past experience within the pharmaceutical industry to guide how new methods are implemented within JMP Clinical, I need your feedback so that the answers you need from your data are within easy reach. In particular, please feel free to share your professional experiences. While there is some literature on methodologies to identify misconduct and quality issues in clinical trials, I suspect the literature is incomplete due to potential fears of admitting such problems exist, or the perceived risk that documenting the experience may pose to your company. If you are unable to publish a particular case study, consider getting in touch. Even a conversation held in the most general of terms may lead to something ...
Get Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
